Breaking News Instant updates and real-time market news.

CRNCY

Cairn Energy

$0.00 /

+ (+0.00%)

05:20
07/08/20
07/08
05:20
07/08/20
05:20

Cairn Energy upgraded to Speculative Buy from Hold at Canaccord

Canaccord analyst Charlie Sharp upgraded Cairn Energy to Speculative Buy from Hold with a 145 GBp price target.

CRNCY Cairn Energy
$0.00 /

+ (+0.00%)

07/01/20 HSBC
Cairn Energy downgraded to Hold from Buy at HSBC
06/03/20 Morgan Stanley
Cairn Energy downgraded to Equal Weight from Overweight at Morgan Stanley
04/29/20 Berenberg
Cairn Energy downgraded to Hold from Buy at Berenberg
04/28/20 Jefferies
Cairn Energy resumed with an Underperform at Jefferies

TODAY'S FREE FLY STORIES

Earnings
Visa names Clorox CEO Rendle to board of directors » 16:19
11/23/20
11/23
16:19
11/23/20
16:19
V

Visa

$208.16 /

+4.29 (+2.10%)

, CLX

Clorox

$202.34 /

-0.64 (-0.32%)

Visa's (V) board of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
V Visa
$208.16 /

+4.29 (+2.10%)

CLX Clorox
$202.34 /

-0.64 (-0.32%)

V Visa
$208.16 /

+4.29 (+2.10%)

11/19/20 Wells Fargo
Visa price target raised to $240 from $210 at Wells Fargo
10/29/20 Wells Fargo
Visa price target lowered to $210 from $230 at Wells Fargo
10/29/20 Oppenheimer
Visa price target lowered to $212 from $233 at Oppenheimer
10/29/20 Credit Suisse
Visa price target lowered to $230 from $235 at Credit Suisse
CLX Clorox
$202.34 /

-0.64 (-0.32%)

11/03/20 RBC Capital
Clorox price target raised to $221 from $218 at RBC Capital
11/03/20 Deutsche Bank
Clorox price target raised to $227 from $223 at Deutsche Bank
11/03/20 Citi
Clorox price target lowered to $238 from $246 at Citi
10/16/20
Fly Intel: Top five analyst downgrades
V Visa
$208.16 /

+4.29 (+2.10%)

CLX Clorox
$202.34 /

-0.64 (-0.32%)

  • 13
    Oct
V Visa
$208.16 /

+4.29 (+2.10%)

CLX Clorox
$202.34 /

-0.64 (-0.32%)

V Visa
$208.16 /

+4.29 (+2.10%)

CLX Clorox
$202.34 /

-0.64 (-0.32%)

V Visa
$208.16 /

+4.29 (+2.10%)

CLX Clorox
$202.34 /

-0.64 (-0.32%)

Initiation
AGNC Investment initiated with a Buy at BTIG » 16:19
11/23/20
11/23
16:19
11/23/20
16:19
AGNC

AGNC Investment

/

+

BTIG analyst Eric Hagen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGNC AGNC Investment
/

+

AGNC AGNC Investment
/

+

07/24/20 Deutsche Bank
Deutsche Bank upgrades AGNC to Buy, sees 20% total return
07/24/20 Deutsche Bank
AGNC Investment upgraded to Buy from Hold at Deutsche Bank
06/24/20 Argus
AGNC Investment initiated with a Buy at Argus
05/04/20 Maxim
AGNC Investment upgraded to Buy from Hold at Maxim
AGNC AGNC Investment
/

+

AGNC AGNC Investment
/

+

AGNC AGNC Investment
/

+

Upgrade
Hennes & Mauritz upgraded to Buy from Sell at Goldman Sachs » 16:18
11/23/20
11/23
16:18
11/23/20
16:18
HNNMY

Hennes & Mauritz

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNNMY Hennes & Mauritz
$0.00 /

+ (+0.00%)

11/18/20 Bernstein
Hennes & Mauritz upgraded to Market Perform from Underperform at Bernstein
10/13/20 AlphaValue
Hennes & Mauritz upgraded to Add from Reduce at AlphaValue
10/05/20 Credit Suisse
Hennes & Mauritz price target raised to SEK 150 from SEK 138 at Credit Suisse
10/02/20 JPMorgan
Hennes & Mauritz price target raised to SEK 195 from SEK 190 at JPMorgan
Earnings
Datto sees FY20 revenue $512.8M-$514.8M, consensus $509.91M » 16:18
11/23/20
11/23
16:18
11/23/20
16:18
MSP

Datto

$26.99 /

-1.35 (-4.76%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$26.99 /

-1.35 (-4.76%)

11/17/20 Citi
Datto initiated with a Neutral at Citi
11/16/20 William Blair
Datto initiated with an Outperform at William Blair
11/16/20 Mizuho
Datto initiated with a Neutral at Mizuho
11/16/20 Morgan Stanley
Datto initiated with an Equal Weight at Morgan Stanley
MSP Datto
$26.99 /

-1.35 (-4.76%)

  • 21
    Oct
MSP Datto
$26.99 /

-1.35 (-4.76%)

Earnings
Fuwei Films reports Q3 net profit RMB 13.5M vs. RMB 3.4M last year » 16:18
11/23/20
11/23
16:18
11/23/20
16:18
FFHL

Fuwei Films

$5.69 /

+0.19 (+3.45%)

Reports Q3 revenue RMB…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FFHL Fuwei Films
$5.69 /

+0.19 (+3.45%)

FFHL Fuwei Films
$5.69 /

+0.19 (+3.45%)

FFHL Fuwei Films
$5.69 /

+0.19 (+3.45%)

Earnings
Datto sees Q4 revenue $133M-$135M, consensus $130.62M » 16:17
11/23/20
11/23
16:17
11/23/20
16:17
MSP

Datto

$26.99 /

-1.35 (-4.76%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$26.99 /

-1.35 (-4.76%)

11/17/20 Citi
Datto initiated with a Neutral at Citi
11/16/20 William Blair
Datto initiated with an Outperform at William Blair
11/16/20 Mizuho
Datto initiated with a Neutral at Mizuho
11/16/20 Morgan Stanley
Datto initiated with an Equal Weight at Morgan Stanley
MSP Datto
$26.99 /

-1.35 (-4.76%)

  • 21
    Oct
MSP Datto
$26.99 /

-1.35 (-4.76%)

Technical Analysis
NASDAQ market internals summary » 16:17
11/23/20
11/23
16:17
11/23/20
16:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Corporate Office Properties names Todd Hartman COO » 16:16
11/23/20
11/23
16:16
11/23/20
16:16
OFC

Corporate Office Properties

$27.30 /

+0.44 (+1.64%)

Corporate Office…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OFC Corporate Office Properties
$27.30 /

+0.44 (+1.64%)

OFC Corporate Office Properties
$27.30 /

+0.44 (+1.64%)

10/27/20 Wells Fargo
Raytheon office reduction negative for office REITs, says Wells Fargo
10/27/20 Raymond James
Corporate Office upgraded at Raymond James, pullback creates good entry point
10/27/20 Raymond James
Corporate Office Properties upgraded to Outperform from Market Perform at Raymond James
08/25/20 JPMorgan
Corporate Office Properties price target raised to $31 from $29 at JPMorgan
OFC Corporate Office Properties
$27.30 /

+0.44 (+1.64%)

Earnings
Datto reports Q3 adjusted EPS 18c, consensus 19c » 16:16
11/23/20
11/23
16:16
11/23/20
16:16
MSP

Datto

$26.99 /

-1.35 (-4.76%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSP Datto
$26.99 /

-1.35 (-4.76%)

11/17/20 Citi
Datto initiated with a Neutral at Citi
11/16/20 William Blair
Datto initiated with an Outperform at William Blair
11/16/20 Mizuho
Datto initiated with a Neutral at Mizuho
11/16/20 Morgan Stanley
Datto initiated with an Equal Weight at Morgan Stanley
  • 21
    Oct
MSP Datto
$26.99 /

-1.35 (-4.76%)

Initiation
AG Mortgage initiated with a Sell at BTIG » 16:16
11/23/20
11/23
16:16
11/23/20
16:16
MITT

AG Mortgage

$3.32 /

+0.23 (+7.44%)

BTIG analyst Eric Hagen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MITT AG Mortgage
$3.32 /

+0.23 (+7.44%)

MITT AG Mortgage
$3.32 /

+0.23 (+7.44%)

05/26/20 Credit Suisse
AG Mortgage downgraded to Underperform from Neutral at Credit Suisse
MITT AG Mortgage
$3.32 /

+0.23 (+7.44%)

MITT AG Mortgage
$3.32 /

+0.23 (+7.44%)

MITT AG Mortgage
$3.32 /

+0.23 (+7.44%)

Technical Analysis
NYSE market internals summary » 16:16
11/23/20
11/23
16:16
11/23/20
16:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Initiation
Score Media and Gaming initiated with a Buy at Canaccord » 16:16
11/23/20
11/23
16:16
11/23/20
16:16
TSCRF

Score Media and Gaming

$0.00 /

+ (+0.00%)

Canaccord initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Spirit of Texas Bancshares names Allison Johnson CFO » 16:15
11/23/20
11/23
16:15
11/23/20
16:15
STXB

Spirit of Texas Bancshares

$15.86 /

-0.27 (-1.67%)

Spirit of Texas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STXB Spirit of Texas Bancshares
$15.86 /

-0.27 (-1.67%)

05/12/20 Stephens
Spirit of Texas Bancshares downgraded to Equal Weight from Overweight at Stephens
12/24/19 DA Davidson
Simmons First National price target raised to $33 from $30 at DA Davidson
STXB Spirit of Texas Bancshares
$15.86 /

-0.27 (-1.67%)

On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:12
11/23/20
11/23
16:12
11/23/20
16:12
AZN

AstraZeneca

$54.62 /

-0.67 (-1.21%)

, REGN

Regeneron

$523.05 /

+3.48 (+0.67%)

, MRK

Merck

$80.30 /

-0.14 (-0.17%)

, BLNK

Blink Charging

$33.77 /

+11.14 (+49.23%)

, RESI

Front Yard Residential

$16.34 /

+2.945 (+21.99%)

, ARES

Ares Management

$44.78 /

-0.24 (-0.53%)

, K

Kellogg

$63.63 /

-1.34 (-2.06%)

, HMI

Huami

$13.59 /

-1.15 (-7.80%)

The major averages began…

ShowHide Related Items >><<
AZN AstraZeneca
$54.62 /

-0.67 (-1.21%)

REGN Regeneron
$523.05 /

+3.48 (+0.67%)

MRK Merck
$80.30 /

-0.14 (-0.17%)

BLNK Blink Charging
$33.77 /

+11.14 (+49.23%)

RESI Front Yard Residential
$16.34 /

+2.945 (+21.99%)

ARES Ares Management
$44.78 /

-0.24 (-0.53%)

K Kellogg
$63.63 /

-1.34 (-2.06%)

HMI Huami
$13.59 /

-1.15 (-7.80%)

AZN AstraZeneca
$54.62 /

-0.67 (-1.21%)

11:53 Today Morgan Stanley
AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley
08:46 Today SVB Leerink
AstraZeneca vaccine 'will never be licensed in the U.S.,' says SVB Leerink
11/11/20 Oppenheimer
Amgen price target raised to $280 from $275 at Oppenheimer
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
REGN Regeneron
$523.05 /

+3.48 (+0.67%)

04:56 Today Piper Sandler
Regeneron Covid cocktail could be meaningful to earnings, says Piper Sandler
11/11/20 Truist
Opthea initiated with a Buy at Truist
11/10/20 SVB Leerink
Regeneron price target lowered to $643 from $653 at SVB Leerink
11/06/20 Truist
Regeneron price target raised to $770 from $750 at Truist
MRK Merck
$80.30 /

-0.14 (-0.17%)

11/10/20 Bernstein
Bernstein bullish on Merck, initiates with an Outperform
11/10/20 Bernstein
Merck initiated with an Outperform at Bernstein
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform at Raymond James
10/23/20
Fly Intel: Pre-market Movers
BLNK Blink Charging
$33.77 /

+11.14 (+49.23%)

08/14/20
Fly Intel: Top five analyst downgrades
08/14/20 H.C. Wainwright
Blink Charging downgraded to Neutral from Buy at H.C. Wainwright
RESI Front Yard Residential
$16.34 /

+2.945 (+21.99%)

10/20/20
Fly Intel: Top five analyst downgrades
10/20/20 Northland
Front Yard Residential downgraded to Market Perform from Outperform at Northland
10/20/20 JMP Securities
Front Yard Residential downgraded to Market Perform from Outperform at JMP Securities
10/20/20 Credit Suisse
Front Yard Residential downgraded to Neutral from Outperform at Credit Suisse
ARES Ares Management
$44.78 /

-0.24 (-0.53%)

05/28/20 BMO Capital
Ares Management upgraded to Outperform from Market Perform at BMO Capital
04/15/20 Wells Fargo
Ares Management price target lowered to $41 from $50 at Wells Fargo
02/18/20 RBC Capital
Ares Management price target raised to $45 from $38 at RBC Capital
02/18/20 BMO Capital
Ares Management price target raised to $41 from $34 at BMO Capital
K Kellogg
$63.63 /

-1.34 (-2.06%)

09:54 Today
Fly Intel: Top five analyst downgrades
06:24 Today Credit Suisse
Credit Suisse downgrades Kellogg ahead of 'disappointing guidance'
06:13 Today Credit Suisse
Kellogg downgraded to Neutral from Outperform at Credit Suisse
10/06/20 Piper Sandler
Piper teen survey shows Snap, Amazon and Apple remain favorites
HMI Huami
$13.59 /

-1.15 (-7.80%)

AZN AstraZeneca
$54.62 /

-0.67 (-1.21%)

REGN Regeneron
$523.05 /

+3.48 (+0.67%)

MRK Merck
$80.30 /

-0.14 (-0.17%)

BLNK Blink Charging
$33.77 /

+11.14 (+49.23%)

RESI Front Yard Residential
$16.34 /

+2.945 (+21.99%)

ARES Ares Management
$44.78 /

-0.24 (-0.53%)

K Kellogg
$63.63 /

-1.34 (-2.06%)

HMI Huami
$13.59 /

-1.15 (-7.80%)

  • 27
    May
AZN AstraZeneca
$54.62 /

-0.67 (-1.21%)

REGN Regeneron
$523.05 /

+3.48 (+0.67%)

MRK Merck
$80.30 /

-0.14 (-0.17%)

BLNK Blink Charging
$33.77 /

+11.14 (+49.23%)

K Kellogg
$63.63 /

-1.34 (-2.06%)

AZN AstraZeneca
$54.62 /

-0.67 (-1.21%)

REGN Regeneron
$523.05 /

+3.48 (+0.67%)

MRK Merck
$80.30 /

-0.14 (-0.17%)

BLNK Blink Charging
$33.77 /

+11.14 (+49.23%)

RESI Front Yard Residential
$16.34 /

+2.945 (+21.99%)

ARES Ares Management
$44.78 /

-0.24 (-0.53%)

K Kellogg
$63.63 /

-1.34 (-2.06%)

HMI Huami
$13.59 /

-1.15 (-7.80%)

AZN AstraZeneca
$54.62 /

-0.67 (-1.21%)

REGN Regeneron
$523.05 /

+3.48 (+0.67%)

MRK Merck
$80.30 /

-0.14 (-0.17%)

BLNK Blink Charging
$33.77 /

+11.14 (+49.23%)

Hot Stocks
FDA grants clearance for Neuronetics' TouchStar treatment » 16:11
11/23/20
11/23
16:11
11/23/20
16:11
STIM

Neuronetics

$7.97 /

+0.07 (+0.89%)

Neuronetics announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STIM Neuronetics
$7.97 /

+0.07 (+0.89%)

STIM Neuronetics
$7.97 /

+0.07 (+0.89%)

10/26/20 Canaccord
Neuronetics price target raised to $8 from $4 at Canaccord
10/06/20 BTIG
Neuronetics price target raised to $10 from $6 at BTIG
07/14/20 Piper Sandler
Investors should take 'fresh look' at Neuronetics after CEO hire, says Piper
05/05/20 William Blair
William Blair downgrades Neuronetics on restructuring uncertainty
STIM Neuronetics
$7.97 /

+0.07 (+0.89%)

STIM Neuronetics
$7.97 /

+0.07 (+0.89%)

Hot Stocks
Agilent falls 5% to $106.20 after Q4 earnings, below-consensus FY21 guidance  16:11
11/23/20
11/23
16:11
11/23/20
16:11
A

Agilent

$111.94 /

+1.04 (+0.94%)

 
ShowHide Related Items >><<
A Agilent
$111.94 /

+1.04 (+0.94%)

A Agilent
$111.94 /

+1.04 (+0.94%)

11/17/20 Cleveland Research
Agilent upgraded to Buy from Neutral at Cleveland Research
11/09/20 KeyBanc
Agilent initiated with an Overweight at KeyBanc
09/30/20 Atlantic Equities
Agilent initiated with a Neutral at Atlantic Equities
08/19/20 Needham
Agilent's Q3 results reflect COVID-19 recovery, says Needham
A Agilent
$111.94 /

+1.04 (+0.94%)

A Agilent
$111.94 /

+1.04 (+0.94%)

A Agilent
$111.94 /

+1.04 (+0.94%)

Hot Stocks
Fulton Financial acquires all outstanding stock of BenefitWorks » 16:09
11/23/20
11/23
16:09
11/23/20
16:09
FULT

Fulton Financial

$12.78 /

+0.24 (+1.91%)

Fulton Bank, N.A., a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FULT Fulton Financial
$12.78 /

+0.24 (+1.91%)

FULT Fulton Financial
$12.78 /

+0.24 (+1.91%)

06/17/20 Raymond James
Fulton Financial upgraded to Outperform from Market Perform at Raymond James
06/01/20 Stephens
Fulton Financial initiated with an Equal Weight at Stephens
FULT Fulton Financial
$12.78 /

+0.24 (+1.91%)

Earnings
Ambarella reports Q3 EPS 9c, consensus 5c » 16:09
11/23/20
11/23
16:09
11/23/20
16:09
AMBA

Ambarella

$66.12 /

-0.33 (-0.50%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$66.12 /

-0.33 (-0.50%)

AMBA Ambarella
$66.12 /

-0.33 (-0.50%)

11/04/20 KeyBanc
KeyBanc lays out possible M&A candidates as semi consolidation heats ups
10/08/20 Rosenblatt
Rosenblatt ups Ambarella target, has 'increasing conviction' on shares
09/21/20 Berenberg
Ambarella initiated with a Buy at Berenberg (Friday)
09/03/20 Craig-Hallum
Ambarella upgraded to Buy at Craig-Hallum
AMBA Ambarella
$66.12 /

-0.33 (-0.50%)

AMBA Ambarella
$66.12 /

-0.33 (-0.50%)

AMBA Ambarella
$66.12 /

-0.33 (-0.50%)

Earnings
Urban Outfitters reports Q3 EPS 78c, consensus 44c » 16:09
11/23/20
11/23
16:09
11/23/20
16:09
URBN

Urban Outfitters

$31.60 /

+1.275 (+4.20%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
URBN Urban Outfitters
$31.60 /

+1.275 (+4.20%)

URBN Urban Outfitters
$31.60 /

+1.275 (+4.20%)

09:09 Today Morgan Stanley
Urban Outfitters price target raised to $30 from $28 at Morgan Stanley
08:10 Today JPMorgan
Urban Outfitters price target raised to $27 from $19 at JPMorgan
11/18/20 B. Riley Securities
Urban Outfitters price target raised to $25 from $20 at B. Riley Securities
11/17/20
Fly Intel: Top five analyst downgrades
URBN Urban Outfitters
$31.60 /

+1.275 (+4.20%)

URBN Urban Outfitters
$31.60 /

+1.275 (+4.20%)

URBN Urban Outfitters
$31.60 /

+1.275 (+4.20%)

URBN Urban Outfitters
$31.60 /

+1.275 (+4.20%)

Hot Stocks
Onto Innovation announces $100M share buyback » 16:08
11/23/20
11/23
16:08
11/23/20
16:08
ONTO

Onto Innovation

$43.12 /

+1.42 (+3.41%)

Onto Innovation Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONTO Onto Innovation
$43.12 /

+1.42 (+3.41%)

ONTO Onto Innovation
$43.12 /

+1.42 (+3.41%)

11/03/20 B. Riley Securities
Onto Innovation price target raised to $51 from $48 at B. Riley Securities
06/11/20 B. Riley FBR
Onto Innovation price target raised to $46 from $40 at B. Riley FBR
06/09/20 DA Davidson
Onto Innovation upgraded to Buy from Neutral at DA Davidson
06/09/20 DA Davidson
Onto Innovation upgraded to Buy from Neutral at DA Davidson
ONTO Onto Innovation
$43.12 /

+1.42 (+3.41%)

Earnings
Agilent sees FY21 EPS $3.57-$3.67, consensus $3.68 » 16:08
11/23/20
11/23
16:08
11/23/20
16:08
A

Agilent

$111.97 /

+1.07 (+0.96%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
A Agilent
$111.97 /

+1.07 (+0.96%)

A Agilent
$111.97 /

+1.07 (+0.96%)

11/17/20 Cleveland Research
Agilent upgraded to Buy from Neutral at Cleveland Research
11/09/20 KeyBanc
Agilent initiated with an Overweight at KeyBanc
09/30/20 Atlantic Equities
Agilent initiated with a Neutral at Atlantic Equities
08/19/20 Needham
Agilent's Q3 results reflect COVID-19 recovery, says Needham
A Agilent
$111.97 /

+1.07 (+0.96%)

A Agilent
$111.97 /

+1.07 (+0.96%)

A Agilent
$111.97 /

+1.07 (+0.96%)

Hot Stocks
Apyx Medical announces FDA approval to start Phase II of U.S. IDE study » 16:07
11/23/20
11/23
16:07
11/23/20
16:07
APYX

Apyx Medical

$6.86 /

+0.1 (+1.48%)

Apyx Medical Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APYX Apyx Medical
$6.86 /

+0.1 (+1.48%)

APYX Apyx Medical
$6.86 /

+0.1 (+1.48%)

06/22/20 Piper Sandler
Apyx Medical's expanded international sale 'important', says Piper Sandler
03/17/20 Piper Sandler
Apyx Medical price target lowered to $7 from $10 at Piper Sandler
01/13/20 JMP Securities
Apyx Medical shares likely to continue to appreciate, says JMP Securities
APYX Apyx Medical
$6.86 /

+0.1 (+1.48%)

APYX Apyx Medical
$6.86 /

+0.1 (+1.48%)

Earnings
Agilentsees sees Q1 EPS 85c-88c, consensus 88c » 16:07
11/23/20
11/23
16:07
11/23/20
16:07
A

Agilent

$111.92 /

+1.015 (+0.92%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
A Agilent
$111.92 /

+1.015 (+0.92%)

A Agilent
$111.92 /

+1.015 (+0.92%)

11/17/20 Cleveland Research
Agilent upgraded to Buy from Neutral at Cleveland Research
11/09/20 KeyBanc
Agilent initiated with an Overweight at KeyBanc
09/30/20 Atlantic Equities
Agilent initiated with a Neutral at Atlantic Equities
08/19/20 Needham
Agilent's Q3 results reflect COVID-19 recovery, says Needham
A Agilent
$111.92 /

+1.015 (+0.92%)

A Agilent
$111.92 /

+1.015 (+0.92%)

A Agilent
$111.92 /

+1.015 (+0.92%)

Initiation
BioCryst initiated with an Outperform at Evercore ISI » 16:06
11/23/20
11/23
16:06
11/23/20
16:06
BCRX

BioCryst

$4.42 /

+0.085 (+1.96%)

Evercore ISI initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$4.42 /

+0.085 (+1.96%)

BCRX BioCryst
$4.42 /

+0.085 (+1.96%)

11/05/20 Piper Sandler
Piper Sandler reiterates Overweight rating on BioCryst ahead of 'busy year-end'
09/30/20 Piper Sandler
Piper says BioCryst's early high dose 9930 data 'impressive'
09/29/20 JPMorgan
BioCryst resumed with an Overweight at JPMorgan
06/26/20 JMP Securities
BioCryst price target raised to $11 from $10 at JMP Securities
BCRX BioCryst
$4.42 /

+0.085 (+1.96%)

  • 28
    May
BCRX BioCryst
$4.42 /

+0.085 (+1.96%)

BCRX BioCryst
$4.42 /

+0.085 (+1.96%)

Syndicate
Advaxis files to sell stock and warrants, no amount given » 16:06
11/23/20
11/23
16:06
11/23/20
16:06
ADXS

Advaxis

$0.39 /

+0.0059 (+1.53%)

A.G.P./Alliance Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADXS Advaxis
$0.39 /

+0.0059 (+1.53%)

ADXS Advaxis
$0.39 /

+0.0059 (+1.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.